Page last updated: 2024-08-17

spironolactone and finasteride

spironolactone has been researched along with finasteride in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (15.69)18.2507
2000's21 (41.18)29.6817
2010's17 (33.33)24.3611
2020's5 (9.80)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Bellavance, E; Luu-The, V; Poirier, D1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chang, L; Lobo, RA; Morris, RS; Spahn, MA; Stanczyk, FZ; Wong, IL1
Shaw, JC1
Durmuşoğlu, F; Erenus, M; Gürbüz, O; Yücelten, D1
Schmidt, JB1
Price, VH; Shapiro, J1
Sinclair, R; Young, R1
Sinclair, RD; Tran, D1
Rittmaster, RS1
Castello, R; Dorizzi, R; Fortunato, A; Moghetti, P; Muggeo, M; Negri, C; Spiazzi, GG; Tosi, F1
Caputo, M; Castello, R; Misciali, C; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Tosti, A1
Mercurio, MG1
Canosa, LF; Ceballos, NR1
Olsen, EA1
Hannuksela, M1
Bayram, F; Everest, H; Keleştimur, F; Unlühizarci K, K1
Lumachi, F; Rondinone, R1
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM1
Bayram, F; Everest, H; Keleştimur, F; Sahin, Y; Unlühizarci, K1
Bandaranayake, I; Mirmirani, P1
Kelestimur, F; Sahin, Y1
Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA1
Al-Inany, H2
Burnham, WM; Edwards, HE; Vimal, S1
Conway, GS; Koulouri, O1
Scheinfeld, N1
Bachelot, A; Chabbert-Buffet, N; Galand-Portier, MB; Kerlan, V; Salenave, S1
Brodell, LA; Mercurio, MG1
Bell, RR; John-Baptiste, A; Levin, S; McMahon, E1
Check, JH; Cohen, R1
Karaca, Z; Kelestimur, F; Unluhizarci, K1
Buzney, C; Buzney, E; Reynolds, RV; Sheu, J1
Bechtel, MA; Harfmann, KL1
Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ1
Ioannides, D; Lazaridou, E1
Vary, JC1
Fedorowicz, Z; van Zuuren, EJ1
Chahal, DS; Hassoun, LA; Larsen, LN; Sivamani, RK1
Clark, AK; Quinonez, RL; Saric, S; Sivamani, RK1
Azarchi, S; Bienenfeld, A; Lo Sicco, K; Marchbein, S; Nagler, AR; Shapiro, J1
Freites-Martinez, A; Geer, EB; Goldfarb, S; Lacouture, ME; Rozner, RN; Shapiro, J1
Kyrgidis, A; Nikolakis, G; Zouboulis, CC1
Cadegiani, FA; Comeche, B; Gioia, F; Goren, A; Herrera, S; Kovacevic, M; McCoy, J; Ramos, PM; Ron, R; Serrano-Villar, S; Shapiro, J; Sinclair, R; Tosti, A; Vaño-Galván, S; Wambier, CG1
Brady, PH; Gin, GT; Rosenblum, E; Wilkinson, LD1
Asrar, MM; Bashir, R; Ganie, MA; Shah, IA; Wani, IA1
Deoghare, S; Sadick, NS1
Hsiao, JL; Jeong, C; Masson, R; Shi, VY; Shih, T1

Reviews

30 review(s) available for spironolactone and finasteride

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antiandrogen therapy in dermatology.
    International journal of dermatology, 1996, Volume: 35, Issue:11

    Topics: Adrenal Cortex Hormones; Androgen Antagonists; Cimetidine; Contraceptives, Oral; Cyproterone Acetate; Finasteride; Flutamide; Humans; Ketoconazole; Skin Diseases; Spironolactone

1996
Hair regrowth. Therapeutic agents.
    Dermatologic clinics, 1998, Volume: 16, Issue:2

    Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone

1998
Hirsutes. II: Treatment.
    The Australasian journal of dermatology, 1998, Volume: 39, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Contraceptives, Oral; Cosmetics; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Hair Removal; Hirsutism; Humans; Laser Therapy; Mineralocorticoid Receptor Antagonists; Prednisolone; Spironolactone

1998
Understanding and managing common baldness.
    Australian family physician, 1999, Volume: 28, Issue:3

    Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome

1999
Antiandrogen treatment of polycystic ovary syndrome.
    Endocrinology and metabolism clinics of North America, 1999, Volume: 28, Issue:2

    Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone

1999
Hirsutism: diagnosis and management.
    The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia, 2001, Volume: 4, Issue:2

    Topics: Adrenal Hyperplasia, Congenital; Androgens; Contraceptives, Oral; Eflornithine; Enzyme Inhibitors; Female; Finasteride; Hair; Hirsutism; Humans; Medical History Taking; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone

2001
[Loss of hair].
    Duodecim; laaketieteellinen aikakauskirja, 2000, Volume: 116, Issue:7

    Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome

2000
Hair loss remedies--separating fact from fiction.
    Cutis, 2004, Volume: 73, Issue:2

    Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents

2004
Medical treatment regimens of hirsutism.
    Reproductive biomedicine online, 2004, Volume: 8, Issue:5

    Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone

2004
Polycystic ovary syndrome.
    Clinical evidence, 2004, Issue:12

    Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone

2004
Polycystic ovary syndrome.
    Clinical evidence, 2005, Issue:14

    Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone

2005
A systematic review of commonly used medical treatments for hirsutism in women.
    Clinical endocrinology, 2008, Volume: 68, Issue:5

    Topics: Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Spironolactone; Thiazolidinediones; Treatment Outcome

2008
A review of hormonal therapy for female pattern (androgenic) alopecia.
    Dermatology online journal, 2008, Mar-15, Volume: 14, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone

2008
Anti-androgen treatments.
    Annales d'endocrinologie, 2010, Volume: 71, Issue:1

    Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Progestins; Spironolactone

2010
Hirsutism: Diagnosis and management.
    Gender medicine, 2010, Volume: 7, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenal Hyperplasia, Congenital; Causality; Contraceptives, Oral; Diagnosis, Differential; Eflornithine; Female; Finasteride; Hair Removal; Hirsutism; Humans; Hypoglycemic Agents; Laser Therapy; Metformin; Mineralocorticoid Receptor Antagonists; Neoplasms; Ornithine Decarboxylase Inhibitors; Polycystic Ovary Syndrome; Spironolactone

2010
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Contraceptives, Oral, Combined; Dermatology; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Life Style; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones

2014
Hair loss in women.
    Clinical obstetrics and gynecology, 2015, Volume: 58, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Finasteride; Flutamide; Hair; Humans; Hypotrichosis; Minoxidil; Phototherapy; Spironolactone; Vasodilator Agents

2015
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    The Cochrane database of systematic reviews, 2015, Apr-28, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone

2015
Female pattern hair loss.
    Current problems in dermatology, 2015, Volume: 47

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents

2015
Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis.
    The Medical clinics of North America, 2015, Volume: 99, Issue:6

    Topics: Acetylcholine Release Inhibitors; Acne Vulgaris; Algorithms; Alopecia; Anti-Bacterial Agents; Antiperspirants; Benzoyl Peroxide; Botulinum Toxins; Contraceptives, Oral, Hormonal; Dermatologic Agents; Finasteride; Hair Follicle; Humans; Hyperhidrosis; Iontophoresis; Mandelic Acids; Minoxidil; Muscarinic Antagonists; Nails; Retinoids; Spironolactone; Sweat Glands; Sympathectomy

2015
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
    The British journal of dermatology, 2016, Volume: 175, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult

2016
The use of hormonal agents in the treatment of acne.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:2

    Topics: Acne Vulgaris; Administration, Oral; Contraceptive Agents; Cortodoxone; Cyproterone Acetate; Dermatologic Agents; Female; Finasteride; Flutamide; Hormones; Humans; Male; Meta-Analysis as Topic; Mineralocorticoid Receptor Antagonists; Propionates; Spironolactone; Treatment Outcome

2016
Hormonal therapies for hidradenitis suppurativa: Review.
    Dermatology online journal, 2017, Nov-12, Volume: 23, Issue:10

    Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral, Hormonal; Dutasteride; Female; Finasteride; Hidradenitis Suppurativa; Hormones; Humans; Male; Spironolactone

2017
Androgens in women: Hormone-modulating therapies for skin disease.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Alopecia; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dutasteride; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Receptors, Androgen; Spironolactone

2019
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
    Breast cancer research and treatment, 2019, Volume: 174, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Finasteride; Hormone Antagonists; Humans; Spironolactone

2019
Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data.
    American journal of clinical dermatology, 2019, Volume: 20, Issue:4

    Topics: Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Therapy, Combination; Finasteride; Hidradenitis Suppurativa; Humans; Metformin; Randomized Controlled Trials as Topic; Skin; Spironolactone; Treatment Outcome

2019
Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
    Current pharmaceutical design, 2023, Volume: 29, Issue:19

    Topics: Androgen Antagonists; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone

2023
Combination therapy in female pattern hair loss.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2023, May-19, Volume: 25, Issue:1-4

    Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Spironolactone; Treatment Outcome

2023
Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
    Journal of drugs in dermatology : JDD, 2023, Aug-01, Volume: 22, Issue:8

    Topics: Finasteride; Flutamide; Hidradenitis Suppurativa; Humans; Liraglutide; Metformin; Spironolactone

2023

Trials

6 trial(s) available for spironolactone and finasteride

ArticleYear
A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
    The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:1

    Topics: Adolescent; Adult; Female; Finasteride; Hair; Hirsutism; Hormones; Humans; Prospective Studies; Spironolactone; Treatment Outcome

1995
Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism.
    Fertility and sterility, 1997, Volume: 68, Issue:6

    Topics: Adult; Drug Administration Schedule; Enzyme Inhibitors; Female; Finasteride; Gonadal Steroid Hormones; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies; Single-Blind Method; Spironolactone; Treatment Outcome

1997
Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:1

    Topics: Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Biomarkers; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hirsutism; Humans; Prostate-Specific Antigen; Spironolactone; Testosterone

2000
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:1

    Topics: Adult; Androgen Antagonists; Double-Blind Method; Female; Finasteride; Flutamide; Hair; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone

2000
Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
    Fertility and sterility, 2003, Volume: 79, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Spironolactone; Testosterone

2003
A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    European journal of endocrinology, 2004, Volume: 150, Issue:3

    Topics: Adult; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Sex Hormone-Binding Globulin; Spironolactone; Testosterone

2004

Other Studies

15 other study(ies) available for spironolactone and finasteride

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity

2009
Other antiandrogens.
    Dermatology (Basel, Switzerland), 1998, Volume: 196, Issue:1

    Topics: Acne Vulgaris; Androgen Antagonists; Cimetidine; Female; Finasteride; Flutamide; Humans; Isotretinoin; Male; Spironolactone

1998
Effects of different steroid-biosynthesis inhibitors on the testicular steroidogenesis of the toad Bufo arenarum.
    Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, 2001, Volume: 171, Issue:6

    Topics: 17-Hydroxysteroid Dehydrogenases; Androgen Antagonists; Androgens; Animals; Bufonidae; Cholestenone 5 alpha-Reductase; Cyanoketone; Dehydroepiandrosterone; Enzyme Inhibitors; Finasteride; Male; Oxidoreductases; Pregnenolone; Spironolactone; Steroid 17-alpha-Hydroxylase; Testis; Testosterone

2001
My hair is thinning on the top of my head. What treatments are available for hair loss in women?
    Health news (Waltham, Mass.), 2002, Volume: 8, Issue:3

    Topics: Alopecia; Diuretics; Enzyme Inhibitors; Female; Finasteride; Humans; Minoxidil; Spironolactone; United States; Vasodilator Agents

2002
Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Fertility and sterility, 2002, Volume: 78, Issue:6

    Topics: Adult; Androgen Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Spironolactone

2002
The treatment of polycystic ovary syndrome.
    Minerva ginecologica, 2004, Volume: 56, Issue:1

    Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss

2004
Evaluation and treatment of male and female pattern hair loss.
    Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone

2005
The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses.
    Epilepsia, 2005, Volume: 46, Issue:12

    Topics: Animals; Animals, Newborn; Anticonvulsants; Desoxycorticosterone; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Mineralocorticoid Receptor Antagonists; Pentylenetetrazole; Rats; Receptors, GABA; Receptors, Mineralocorticoid; Receptors, Progesterone; Seizures; Spironolactone

2005
Prostate effect in dogs with the aldosterone receptor blocker eplerenone.
    Toxicologic pathology, 2013, Volume: 41, Issue:2

    Topics: Animals; Atrophy; Dihydrotestosterone; Dogs; Eplerenone; Finasteride; Histocytochemistry; Male; Mineralocorticoid Receptor Antagonists; Organ Size; Prostate; Protein Binding; Receptors, Androgen; Spironolactone

2013
Dihydrotestosterone may contribute to the development of migraine headaches.
    Clinical and experimental obstetrics & gynecology, 2013, Volume: 40, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral; Dextroamphetamine; Dihydrotestosterone; Female; Finasteride; Humans; Migraine Disorders; Polycystic Ovary Syndrome; Spironolactone; Young Adult

2013
Hirsutism - from diagnosis to use of antiandrogens.
    Frontiers of hormone research, 2013, Volume: 40

    Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone

2013
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2021, Volume: 35, Issue:1

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; COVID-19; Dutasteride; Finasteride; Humans; Intensive Care Units; Male; Middle Aged; Observational Studies as Topic; Patient Admission; Prospective Studies; SARS-CoV-2; Spironolactone

2021
Female Pelvic Conditions: Polycystic Ovary Syndrome.
    FP essentials, 2022, Volume: 515

    Topics: Acne Vulgaris; Anovulation; Female; Finasteride; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Infertility; Letrozole; Male; Obesity; Polycystic Ovary Syndrome; Spironolactone; Weight Loss

2022